TriVAD: Successful use of Impella 5.5 and Protek Duo CentriMag RVAD following Heartware HVAD thrombosis as a bridge to heart transplant.

IF 1.1 4区医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Perfusion-Uk Pub Date : 2024-10-04 DOI:10.1177/02676591241289841

Edward Chiou, Connor Lewis, Christina Creel-Bulos, Casey F Miller, Joshua L Chan, Mani A Daneshmand

{"title":"TriVAD: Successful use of Impella 5.5 and Protek Duo CentriMag RVAD following Heartware HVAD thrombosis as a bridge to heart transplant.","authors":"Edward Chiou, Connor Lewis, Christina Creel-Bulos, Casey F Miller, Joshua L Chan, Mani A Daneshmand","doi":"10.1177/02676591241289841","DOIUrl":null,"url":null,"abstract":"Introduction: Pump thrombosis remains a feared complication following placement of durable left ventricular assist devices (LVAD) and can be particularly detrimental to individuals being bridged to heart transplantation. Complications associated with this malfunction not only increase morbidity related to right heart failure, hemolysis, and other organ failure, but may ultimately jeopardize a patient's heart transplant candidacy. Additionally, reoperation for durable ventricular device replacement not only poses additional surgical risks to patients but can potentially complicate or even prohibit transplantation in the future.Case report: This case report describes a novel configuration of temporary, groin-free, percutaneously-deployed biventricular mechanical circulatory devices to support a patient with biventricular failure due to partial LVAD thrombosis.Discussion/conclusion: The use of less invasive mechanical support measures, such as the approach described here, may help patients achieve adequate hemodynamic support while allowing them to remain ambulatory and facilitate successful bridging to heart transplantation.","PeriodicalId":49707,"journal":{"name":"Perfusion-Uk","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2024-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Perfusion-Uk","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/02676591241289841","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: Pump thrombosis remains a feared complication following placement of durable left ventricular assist devices (LVAD) and can be particularly detrimental to individuals being bridged to heart transplantation. Complications associated with this malfunction not only increase morbidity related to right heart failure, hemolysis, and other organ failure, but may ultimately jeopardize a patient's heart transplant candidacy. Additionally, reoperation for durable ventricular device replacement not only poses additional surgical risks to patients but can potentially complicate or even prohibit transplantation in the future.

Case report: This case report describes a novel configuration of temporary, groin-free, percutaneously-deployed biventricular mechanical circulatory devices to support a patient with biventricular failure due to partial LVAD thrombosis.

Discussion/conclusion: The use of less invasive mechanical support measures, such as the approach described here, may help patients achieve adequate hemodynamic support while allowing them to remain ambulatory and facilitate successful bridging to heart transplantation.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

TriVAD：在Heartware HVAD血栓形成后成功使用Impella 5.5和Protek Duo CentriMag RVAD作为心脏移植的桥梁。

导言：泵血栓仍是植入耐用左心室辅助装置（LVAD）后的一种令人担忧的并发症，尤其是对心脏移植的患者不利。与这种故障相关的并发症不仅会增加与右心衰竭、溶血和其他器官衰竭相关的发病率，还可能最终危及患者的心脏移植候选资格。此外，为更换耐用心室装置而再次手术不仅会给患者带来额外的手术风险，而且有可能使移植手术复杂化，甚至禁止移植手术：本病例报告描述了一种新颖的临时性、无腹股沟、经皮部署的双心室机械循环装置配置，用于支持一名因 LVAD 部分血栓形成而导致双心室衰竭的患者：讨论/结论：使用创伤较小的机械支持措施（如本文所述方法）可帮助患者获得足够的血流动力学支持，同时使他们能够保持行动自如，并有助于成功过渡到心脏移植。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Perfusion-Uk 医学-外周血管病

CiteScore

3.00

自引率

8.30%

发文量

203

审稿时长

6-12 weeks

期刊介绍： Perfusion is an ISI-ranked, peer-reviewed scholarly journal, which provides current information on all aspects of perfusion, oxygenation and biocompatibility and their use in modern cardiac surgery. The journal is at the forefront of international research and development and presents an appropriately multidisciplinary approach to perfusion science.